You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Send
Operator working in a drug manufacturing

Containment of APIs released through component washing

Topics

Containment of APIs released through component washing

Personnel and environmental safety are critical for pharmaceutical companies that manufacture drugs with hazardous or potentially hazardous Active Pharmaceutical Ingredients (APIs).

APIs are a normal byproduct of pharmaceutical production, research and development that can be released into the loading and service area via the component cleaning/washing process.

Pharmaceutical companies that manufacture drugs with hazardous or potentially hazardous APIs, therefore, need a solution that works with cGMP washers to ensure the safety of personnel and the environment during the cleaning of drug manufacturing equipment and component parts.

The Solution

The Getinge Air Exhaust Unit is an optional, standalone solution that captures potent and highly potent APIs and prevents their release into the production, service, and loading areas.

Mitigation of trace API residuals emitted after a component washing cycle through the use of an Air Exhaust Unit can reduce worker exposure near the washing process.

The system uses a highly effective bag-in, bag-out HEPA filtration system to capture the residual HPAPIs and APIs removed during the equipment cleaning process, which prevents the release into the service and other adjacent areas.

In addition, the Air Exhaust Unit provides level 5 OEB containment for the highest level of personal safety from API particulates.

oeb-containment-level.JPG

Download the application brief here:

air-exhaust-unit-cgmp-gew-wahers-application-brief-mockup.jpg

Related articles

  • Pharmaceutical Production

Optimized Handling of DPTE-BetaBag® Tyvek® in steam sterilization

Following specified load and autoclave cycle parameters will result in the best performance for DPTE-BetaBag® Tyvek®. These easy steps will improve outcomes and reduce the risk of bag failure. Understand how the performance of the DPTE-BetaBag® Tyvek will be optimized by using proper procedures.

Learn more

  • Pharmaceutical Production

How to speed up aseptic liquid transfer while maintaining sterility?

The single-use DPTE-BetaBag® is playing an increasingly important role in scale-up and high-speed manufacturing operations by providing an aseptic liquid transfer solution that delivers on safety and sterility. Especially in final filtration and filling operations, maintaining sterility throughout the entire process is critical.

Learn more

  • Pharmaceutical Production

Getinge and IMA Life create flexible solutions for the pharma and biopharma industries

In some projects IMA Life works together with Getinge to find advanced solutions to meet the most demanding customer needs.

Learn more

  • Pharmaceutical Production

Improving industry-standard DPTE-BetaBag® validation

Educated in the Control and Development of Pharmaceutical Products, Sophie Corbineau worked in pharmaceutical production for eight years, before joining Getinge as a Validation Expert in 2015.

Learn more

  • Pharmaceutical Production

Which DPTE® solution is best for you?

The Original DPTE® system from Getinge is the world's leading sterile transfer solution. A fully validated system, DPTE® is available with both single-use DPTE-BetaBag® and reusable Beta Containers to match your needs. Learn more about the advantages of each solution.

Learn more

  • Pharmaceutical Production

The benefits of the complete DPTE® system

The original DPTE® system from Getinge is the world's leading sterile transfer solution.The most important advantage of using both DPTE® Alpha and DPTE® Beta components is that as one complete system it is validated by Getinge.

Learn more